Pro Medicus Limited (OTCMKTS:PMCUF) Sees Significant Drop in Short Interest

Pro Medicus Limited (OTCMKTS:PMCUF) saw a significant decline in short interest during the month of February. As of February 27th, there was short interest totaling 401,116 shares, a decline of 19.9% from the February 12th total of 500,825 shares. Based on an average daily trading volume, of 378 shares, the short-interest ratio is presently 1,061.2 days. Based on an average daily trading volume, of 378 shares, the short-interest ratio is presently 1,061.2 days.

Pro Medicus Stock Performance

OTCMKTS PMCUF opened at $94.03 on Tuesday. Pro Medicus has a 1 year low of $74.52 and a 1 year high of $218.25. The stock’s 50-day moving average price is $108.54 and its two-hundred day moving average price is $151.24.

Wall Street Analyst Weigh In

Separately, Jefferies Financial Group set a $155.00 target price on Pro Medicus and gave the company a “buy” rating in a research note on Thursday, February 12th. One research analyst has rated the stock with a Buy rating, According to MarketBeat.com, the company has an average rating of “Buy” and a consensus price target of $155.00.

Pro Medicus Company Profile

Pro Medicus Limited is an Australia‐based healthcare technology company specializing in advanced medical imaging IT solutions. Its core offerings include radiology information systems (RIS), picture archiving and communication systems (PACS), and enterprise imaging platforms designed to streamline diagnostic workflows and enhance image management for healthcare providers.

The company’s flagship product suite, Visage 7, delivers high-performance visualization and reporting capabilities, enabling radiologists to access and manipulate large datasets with minimal latency.